Invivyd (IVVD) Cash & Equivalents (2020 - 2025)

Invivyd (IVVD) posted Cash & Equivalents of $226.7 million for Q4 2025, up 166.8% on a QoQ basis from $85.0 million in Q3 2025, and up 226.88% year-over-year from $69.3 million in Q4 2024.

Invivyd (IVVD) Cash & Equivalents (2020 - 2025) Analysis & Trends

Invivyd's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $226.7 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 226.88% year-over-year to $226.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $226.7 million (up 226.88% YoY) and the FY2025 annual result came in at $226.7 million, up 226.88% from the prior year.
  • Cash & Equivalents was $226.7 million for Q4 2025 at Invivyd, up from $85.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $542.2 million in Q4 2021 and bottomed at $34.9 million in Q2 2025.
  • A 5-year average of $227.9 million and a median of $181.8 million in 2023 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2021 — Cash & Equivalents jumped 371.55% — and 2022, when it tumbled 83.02%.
  • Invivyd's Cash & Equivalents stood at $542.2 million in 2021, then tumbled by 83.02% to $92.1 million in 2022, then surged by 117.91% to $200.6 million in 2023, then plunged by 65.44% to $69.3 million in 2024, then jumped by 226.88% to $226.7 million in 2025.
  • Business Quant data shows IVVD's Cash & Equivalents at $226.7 million in Q4 2025, $85.0 million in Q3 2025, and $34.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 82.45 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 2.83 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 440.94 Mn
10 Invivyd 104.07 Mn -122.62 Mn 16.07 Mn 226.69 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 226.69 Mn
Sep 30, 2025 84.97 Mn
Jun 30, 2025 34.91 Mn
Mar 31, 2025 48.08 Mn
Dec 31, 2024 69.35 Mn
Sep 30, 2024 106.87 Mn
Jun 30, 2024 147.88 Mn
Mar 31, 2024 189.39 Mn
Dec 31, 2023 200.64 Mn
Sep 30, 2023 181.82 Mn
Jun 30, 2023 121.95 Mn
Mar 31, 2023 126.47 Mn
Dec 31, 2022 92.08 Mn
Sep 30, 2022 278.15 Mn
Jun 30, 2022 474.89 Mn
Mar 31, 2022 532.22 Mn
Dec 31, 2021 542.22 Mn
Sep 30, 2021 478.27 Mn
Jun 30, 2021 392.51 Mn
Dec 31, 2020 114.99 Mn